These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 6719111

  • 1. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
    Igisu H, Suzuki K.
    Science; 1984 May 18; 224(4650):753-5. PubMed ID: 6719111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.
    Kobayashi T, Shinoda H, Goto I, Yamanaka T, Suzuki Y.
    Biochem Biophys Res Commun; 1987 Apr 14; 144(1):41-6. PubMed ID: 3579916
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA, Shea L, Jiang X, Hunter DA, Guzman AM, Reddy AS, Qin EY, Li Y, Gray SJ, Ory DS, Sands MS.
    J Neurosci; 2015 Apr 22; 35(16):6495-505. PubMed ID: 25904800
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.
    Belleri M, Ronca R, Coltrini D, Nico B, Ribatti D, Poliani PL, Giacomini A, Alessi P, Marchesini S, Santos MB, Bongarzone ER, Presta M.
    Brain; 2013 Sep 22; 136(Pt 9):2859-75. PubMed ID: 23983033
    [Abstract] [Full Text] [Related]

  • 9. Infantile and fetal globoid cell leukodystrophy: analysis of galactosylceramide and galactosylsphingosine.
    Kobayashi T, Goto I, Yamanaka T, Suzuki Y, Nakano T, Suzuki K.
    Ann Neurol; 1988 Oct 22; 24(4):517-22. PubMed ID: 3239954
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target.
    Li Y, Xu Y, Benitez BA, Nagree MS, Dearborn JT, Jiang X, Guzman MA, Woloszynek JC, Giaramita A, Yip BK, Elsbernd J, Babcock MC, Lo M, Fowler SC, Wozniak DF, Vogler CA, Medin JA, Crawford BE, Sands MS.
    Proc Natl Acad Sci U S A; 2019 Oct 01; 116(40):20097-20103. PubMed ID: 31527255
    [Abstract] [Full Text] [Related]

  • 17. Developmental defects and aberrant accumulation of endogenous psychosine in oligodendrocytes in a murine model of Krabbe disease.
    Inamura N, Kito M, Go S, Kishi S, Hosokawa M, Asai K, Takakura N, Takebayashi H, Matsuda J, Enokido Y.
    Neurobiol Dis; 2018 Dec 01; 120():51-62. PubMed ID: 30176352
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.